South Africa is seeking to produce a key HIV prevention drug locally as part of a broader effort to improve access to treatment and strengthen the country’s pharmaceutical industry.
The government is working with international partners, including Unitaid and United States Pharmacopeia, to identify a domestic manufacturer capable of producing the long-acting HIV prevention medicine lenacapavir.
The government is working with international partners, including Unitaid and United States Pharmacopeia, to identify a domestic manufacturer capable of producing the long-acting HIV prevention medicine lenacapavir.
- Category
- South Africa
Be the first to comment
Up Next
Autoplay
-
02:17
Kenya rolls out twice-yearly HIV prevention shot in Nairobi slum
-
02:13
New HIV treatment drug welcomed in the Eastern Cape
-
02:43
Nigeria Fails To Cut Down Oil Production Despite Calls For Production Cut
-
01:12
South Africa gives twice-yearly HIV prevention jab the green light
-
02:29
Zimbabwe roll-out of long-acting HIV prevention drug gets underway
-
02:02
Declining Trade With South Africa Boosts Local Production
-
01:53
Women In Cameroon Meet In Hair Salons To Discuss HIV Awareness, Prevention
-
03:19
Govt’s new HIV prevention injection receives strong support from key populations
-
01:05
Kenya to roll out game-changing HIV drug in March
-
01:02
Zimbabwe launches groundbreaking HIV prevention drug Lenacapavir
-
59:15
The Chinese are Coming
-
01:55
Sudan: Miners face harsh conditions as they search for gold in desert
-
03:11
Mugabe: Zanu PF Says Heroes Acre Only For Party Supporters
-
01:30
Coronavirus: South Sudan reports first case
-
01:12
Polls open in Zambia elections, President Edgar Lungu casts vote
